Patent · US Active

Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof

US8540968B2 · kind B2 · utility

10Cited by
16References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2005
Grant dateSep 24, 2013
Priority date
Expiry dateDec 31, 2028

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/57492
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for treating, detecting and locating recurrence of cancer, radiation and chemo insensitive cancer or metastasis of cancer selected from the group consisting of Lung cancer, Adrenal cancer, Melanoma, Colon cancer, Colorectal cancer, Ovarian cancer, Prostate cancer, Liver cancer, Subcutaneous cancer, Squamous cell cancer, Intestinal cancer, Hepatocellular carcinoma, Retinoblastoma, Cervical cancer, Glioma, Breast cancer and Pancreatic cancer in subject using phospholipid ether analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.